Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER

Title
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Authors
Keywords
Rotigotine transdermal system, Open-label, Clinical trial, Parkinson’s disease
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 120, Issue 7, Pages 1069-1081
Publisher
Springer Nature
Online
2012-12-03
DOI
10.1007/s00702-012-0925-5

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started